Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Newly discovered organelle could help prevent cancer

Scientists at the University of Virginia School of Medicine have discovered a strange new organelle inside our cells that helps to prevent cancer by ensuring that genetic material is sorted correctly as cells divide.

22 Oct 2019

IBD far more common than expected, and will only increase in future

There are three times as many people with the chronic and debilitating bowel disorder called inflammatory bowel disease (IBD) as ever thought before, according to a new study presented today at UEG Week 2019, at Barcelona. Not only is the condition a distressing one in itself, but patients with IBD have a higher risk of colorectal cancer as well.

21 Oct 2019

Researchers identify an immune cell that helps keep time in the gut

As people go through their daily and nightly routines, their digestive tracts follow a routine, too: digesting food and absorbing nutrients during waking hours, and replenishing worn-out cells during sleep. Shift work and jet lag can knock sleep schedules and digestive rhythms out of whack.

4 Oct 2019

UC Davis researchers awarded $1.5 million NIH grant for CRISPR cancer treatment

What if, instead of killing cancer cells or cells about to become cancerous, you could deliver a repair package and fix them? UC Davis researchers have just been awarded $1.5 million from the National Institutes of Health to start work towards that goal.

3 Oct 2019

Innovative drug treatment developed for familial adenomatous polyposis

Researchers from Tel Aviv University and Tel Aviv Sourasky Medical Center (Ichilov Hospital) have developed an innovative drug treatment for familial adenomatous polyposis (FAP), a rare, inherited condition that affects adolescents and young adults and often leads to colorectal cancer.

3 Oct 2019

Increased intake of dietary fiber lowers risk of hypertension and type 2 diabetes

Dietary fiber has been found to reduce the risk of high blood pressure and type 2 diabetes in a study presented at the American College of Cardiology Middle East Conference 2019.

3 Oct 2019

Innovative compound kills cancer cells, minimizes damage to normal tissues

Most of the current clinical anti-tumor drugs used in chemotherapy move around in the patient's blood after intake and are unable to pinpoint the targeted tumor. As a result, while killing the tumor cells, the healthy cells may also be killed as "collateral damage", leading to undesired side effects.

3 Oct 2019

Certain fungi increase pancreatic cancer risk, study finds

Certain fungi move from the gut to the pancreas, expand their population more than a thousand-fold, and encourage pancreatic cancer growth, a new study finds.

2 Oct 2019

Triplet therapy could benefit patients with BRAF-mutant metastatic colorectal cancer

Results presented today at the ESMO Congress 2019, Barcelona 27 September - 01 October, during the second Proffered Paper Session on Gastrointestinal tumors (colorectal) by VHIO's Director, Josep Tabernero, show that the triplet combination of the BRAF inhibitor, encorafenib, MEK inhibitor, binimetinib, and EGFR inhibitor, cetuximab, not only significantly improves overall survival but also increases objective response rates compared with standard of care in patients with BRAF V600E-mutant metastatic colorectal cancer.

30 Sep 2019

New trial shows improved survival for patients with advanced colorectal BRAF-mutant cancer

A clinical trial has shown that using a combination of three drugs that target a BRAF gene mutation in patients with mCRC effectively boosts overall survival.

30 Sep 2019

Study: Three-drug combination improves overall survival in patients with mCRC

The three-drug combination of encorafenib, binimetinib and cetuximab significantly improved overall survival (OS) in patients with BRAF-mutated metastatic colorectal cancer (mCRC), according to results of the BEACON CRC Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

30 Sep 2019

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

A metabolic imbalance in some cancer patients following treatment with a checkpoint inhibitor drug, nivolumab, is associated with resistance to the immunotherapy agent and shorter survival, report scientists from Dana-Farber Cancer Institute, in collaborative work with the Broad Institute of MIT and Harvard.

25 Sep 2019

Global survey highlights unmet need of women living with cancer

Merck, a leading science and technology company, today released the Supporting Women With Cancer report, presenting findings from a global survey of 4,585 women across 23 countries.

25 Sep 2019

Web-based tool predicts risks of conditions in middle-aged women

A web-based calculator that helps middle-aged women predict their risks of conditions that become more likely with age has been developed by public health, medical and computer science experts from throughout the U.S. and Saudi Arabia.

25 Sep 2019

Onion and garlic may reduce risk of breast cancer

Onion and garlic are staple spices for many cuisines across the globe. There are numerous recipes requiring these two elements, and they may now be key ingredients in cutting the risk of breast cancer.

24 Sep 2019

Discrete choice experiments can predict real-world healthcare choices, research shows

Value in Health, the official journal of ISPOR- the professional society for health economics and outcomes research, announced today the publication of research demonstrating that discrete choice experiments are able to predict real-world healthcare choices.

23 Sep 2019

Research shows how bowel cancer screening helps reduce deaths

New research led by the University of South Australia shows just how effective bowel cancer screening is in helping to reduce the number of bowel cancer deaths by up to 45 per cent.

20 Sep 2019

Study finds increase in health gap between First Nation people and other Manitobans

The health gap between First Nation people and all other Manitobans is growing.

20 Sep 2019

Microrna-based therapy may prove to be effective against chemotherapy-resistant cancers

A technology that manipulates microRNAs developed by Jingfang Ju, PhD, a biochemist and Professor in the Department of Pathology at the Renaissance School of Medicine at Stony Brook University, and colleagues has shown promise when used as anti-cancer therapeutic.

19 Sep 2019

Roswell Park moving three-pronged immunotherapy strategy forward with support from DoD grant

A team from Roswell Park Comprehensive Cancer Center is moving a new three-part strategy for treating advanced cancers forward with support from a U.S. Department of Defense grant to Pawel Kalinski, MD, PhD, Vice Chair for Translational Research and Rustum Family Professor for Molecular Therapeutics and Translational Research at the Buffalo, N.Y.-based cancer center.

18 Sep 2019

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Newly discovered organelle could help prevent cancer

IBD far more common than expected, and will only increase in future

Researchers identify an immune cell that helps keep time in the gut

UC Davis researchers awarded $1.5 million NIH grant for CRISPR cancer treatment

Innovative drug treatment developed for familial adenomatous polyposis

Increased intake of dietary fiber lowers risk of hypertension and type 2 diabetes

Innovative compound kills cancer cells, minimizes damage to normal tissues

Certain fungi increase pancreatic cancer risk, study finds

Triplet therapy could benefit patients with BRAF-mutant metastatic colorectal cancer

New trial shows improved survival for patients with advanced colorectal BRAF-mutant cancer

Study: Three-drug combination improves overall survival in patients with mCRC

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

Global survey highlights unmet need of women living with cancer

Web-based tool predicts risks of conditions in middle-aged women

Onion and garlic may reduce risk of breast cancer

Discrete choice experiments can predict real-world healthcare choices, research shows

Research shows how bowel cancer screening helps reduce deaths

Study finds increase in health gap between First Nation people and other Manitobans

Microrna-based therapy may prove to be effective against chemotherapy-resistant cancers

Roswell Park moving three-pronged immunotherapy strategy forward with support from DoD grant

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in